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Cell lines are essential tools to standardize and compare experimental findings in basic and translational cancer
research. The current dogma states that cancer stem cells feature an increased tumor initiation capacity and are
also chemoresistant. Here, we identified and comprehensively characterized three morphologically distinct cellular
subtypes in the non–small cell lung cancer cell line A549 and challenge the current cancer stem cell dogma.
Subtype-specific cellular morphology is maintained during short-term culturing, resulting in the formation of
holoclonal, meroclonal, and paraclonal colonies. A549 holoclone cells were characterized by an epithelial and
stem-like phenotype, paraclone cells featured a mesenchymal phenotype, whereas meroclone cells were
phenotypically intermediate. Cell-surface marker expression of subpopulations changed over time, indicating an
active epithelial-to-mesenchymal transition (EMT), in vitro and in vivo. EMT has been associated with the
overexpression of the immunomodulators PD-L1 and PD-L2, which were 37- and 235-fold overexpressed in para-
versus holoclone cells, respectively. We found that DNA methylation is involved in epigenetic regulation of marker
expression. Holoclone cells were extremely sensitive to cisplatin and radiotherapy in vitro, whereas paraclone cells
were highly resistant. However, inhibition of the receptor tyrosine kinase AXL, whose expression is associatedunding: This work was supported by the Bernese Cancer League and the Swiss Cancer
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186 Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 Tièche et al. Neoplasia Vol. 21, No. 2, 2019with an EMT, specifically targeted the otherwise highly resistant paraclone cells. Xenograft tumor formation
capacity was 24- and 269-fold higher in holo- than mero- and paraclone cells, respectively. Our results show that
A549 subpopulations might serve as a unique system to explore the network of stemness, cellular plasticity, tumor
initiation capacity, invasive and metastatic potential, and chemo/radiotherapy resistance.
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ung cancer is the most common cause of cancer-related mortality
orldwide. More than 80% of lung tumors are non–small cell lung
ncers (NSCLCs). A growing body of evidence identified subpop-
ations of cancer stem cells (CSCs) in various solid tumors that are
aracterized by an increased expression of stemness-associated genes
d drive tumor initiation and therapy resistance (reviewed in [1]).
hemotherapy-resistant subpopulations of cells characterized by CSC
arker expression were also identified in lung cancer [2,3].
terestingly, treatment-resistant lung CSCs displayed an epithelial-
-mesenchymal transition (EMT) phenotype. Indeed, it was
oposed that EMT, CSCs, and drug resistance are intrinsically
ked (reviewed in [1]).
EMT is a developmental program employed during embryogenesis
d in adult organs during wound healing. The activation of this
ogram in cancer cells leads to heritable genetic changes via epigenetic
odifications, without the acquisition of new genetic alterations. Upon
tivation of the program, carcinoma cells shed their epithelial
enotype (e.g., cell-to-cell junctions, polarity, and epithelial marker
pression). Instead, they acquire a mesenchymal phenotype, which is
sociated with therapy resistance and characterized by a fibroblast-like,
ongated morphology and an increased migration and invasion
pacity (reviewed in [1]). Cisplatin-resistant NSCLC sublines
splayed a putative stemness gene signature characterized by increased
pression of NANOG, Oct4, and Sox2, which was accompanied by
creased expression of CSCmarkers CD133 and CD44. Interestingly,
ose cells also featured higher expression of the EMT markers c-Met
d Beta-catenin, indicating a hybrid epithelial/mesenchymal (hybrid-
/M) state [4]. The hybrid-E/M state was also described in lung
enocarcinoma cell lines [5].
Primary normal human epidermal cells are heterogeneous in their
stained growth [6]. Single cells give rise to three types of colonies,
rmed holoclones, meroclones, and paraclones. Holoclones have the
eatest reproductive capacity (i.e., extensive proliferation and self-
newal) and, after reseeding, give rise to compact colonies with intact
lony borders. Paraclones exclusively contain cells with a short
plicative lifespan, which give rise to colonies with wrinkled or
srupted colony borders after reseeding. The meroclone is a
ansitional stage between the holoclone and paraclone. Holo-,
ero-, and paraclones were also described in human cancer cell lines
g, pancreatic carcinoma [7], glioma, head and neck squamous cell
rcinoma, breast and prostate carcinoma cell lines [8–11]). However,
hereas the transition from holo- to mero- and paraclone has been
scribed as unidirectional [6], the transition between the different
ates might not be as restricted in malignant cells. Indeed,
enotypic plasticity has been described in vitro in ovarian, breast,
d lung cancer cell lines, including plasticity of CD133 expression in
e cell line A549 [12–14].The A549 adenocarcinoma cell line was derived from human
rcinomatous lung tissue by Giard et al. [15] and has been widely
udied, resulting in more than 19,500 citations in www.pubmed.org
date. Ye et al. [16] identified three types of colonies in the parental
549 cell line, which they described, based on the colony
orphology, as holo-, meta-, and paraclones. However, to the best
our knowledge, no report characterizes the distinct cell types
mposing the parental A549 cell line in detail.
In summary, our study indicates that an untreated in vitro culture of
e parental cell line A549 is composed of unique subpopulations of
lls characterized by distinct features, i.e., tumor initiation capacity,
emotherapy resistance, EMT, and migration/invasion capacity.aterials and Methods
ull details are provided in SI Materials and Methods.
Vitro Cell Culture and Experiments
Cell lines were cultured as described [17]. Details of the procedure
establish holo-, mero-, and paraclonal subcultures and the in vitro
periments are described in SI Materials and Methods.
NA Sequencing and Data Analysis
Illumina paired end sequencing was performed with RNA libraries
epared from three A549 parental cultures plus three subcultures of
ch type.
munofluorescence Microscopy
Cells were seeded at a density of approximately 1 cell/mm2 and
ltured for 6 days. Cells were fixed in paraformaldehyde and
bsequently stained for immunofluorescence analysis.
low Cytometry
Cells were stained for extracellular markers, fixed, permeabilized,
ained for intracellular markers and DNA, and analyzed by flow
tometry.
nimal Experiments and Extreme Limiting Dilution Analysis
Mouse studies were conducted in accordance with Institutional Animal
are and Ethical Committee–approved animal guidelines and protocols.
munohistochemical Staining
Tissue was fixed and embedded in paraffin. Immunohistochemical
aining was performed using an automated immunostainer.
ethylation Analysis
Genomic DNA was converted by bisulfite treatment; promoter
gions of CDH1 and SNAI2 were amplified by PCR and sequenced,
lowing the quantitation of methylated CpG sites.
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Figure 1. Parental A549 cell cultures contain morphologically distinct cells that give rise to holo-, mero-, and paraclonal colonies. (A) Phase
contrast microscopy images of clonal cultures from parental A549 (P), holoclone (1.1), meroclone (2.2), and paraclone cells (3.2). (B)
Quantification of area, numbers, and ratios thereof from holo-, mero-, and paraclone cells/colonies by immunofluorescence imaging. All
quantifications were made with three individual clonal cultures of holo- (1.1, 1.5, 1.10), mero- (2.2, 2.3, 2.4), and paraclones (3.2, 3.4, 3.7)
for which at least 12 colonies (n = 36) or 15 cells and nuclei (n = 45) were analyzed. Ordinary one-way ANOVA was used for significance
analysis (*P b .05, **P b .01, ***P b .001, ****P b .0001; n.s., not significant).
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entification of Morphologically Distinct Colonies in the A549
ell Line
Our previous study indicated that morphologically distinct
lonies are identifiable after plating the parental cell line A549 at
w density [17]. Indeed, starting from a new aliquot of A549 cells
dered directly from ATCC, phenotypically different colonies were
adily identifiable after a few (~3) amplification passages. In detail,ase contrast microscopy revealed three cell and colony morphol-
ies (Figure 1A, Parental A549). Based on the published work [6] on
ltures of primary human keratinocytes, the clones were termed
lo-, mero-, and paraclones. Their frequencies in the parental A549
ll line were 10%, 50%, and 40%, respectively, as we reported [17].
o further characterize these subpopulations, we started from single
lonies isolated by cloning rings and removed morphologically
verting colonies over several passages (see the Material and Methods
ction and Suppl. Figure 1A, three distinct subtypes), thereby
es
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188 Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 Tièche et al. Neoplasia Vol. 21, No. 2, 2019tablishing clonal cell cultures characterized by a homogenous colony
orphology (Figure 1A and Suppl. Figure 1B).
We detected no differences in cell and colony morphology in the
SCLC cell lines NCI-H460 and NCI-H358. Although we detected
lonies with differences in morphology, we could not establish stable
ng-term cultures of different H2405 subtypes. Six days after
eding, A549 holoclone cells gave rise to round colonies with sharply
lineated colony borders and small tightly packed cells (Suppl.A C
D
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gure 2. A549 subtypes feature distinct expression patterns. (A) Princi
ltures (1.1, 1.2, 1.5) in green, meroclonal cultures (2.2, 2.3, 2.4) in cy
ltures in red. PC1: 61% variance, PC2: 15% variance. (B) Venn diagra
btypes compared to parental cells. (C) Expression of selected gene
rental. (D) Quantification of fluorescence signal intensity (minus bac
icroscopy. Y-axis represents mean signal intensity ± SD of three sub
d paraclone cells (3.2, 3.4, 3.7) (n = 80). Ordinary one-way ANOVAwa
**P b .0001).igure 1C). In agreement with the initial observation by Barrandon
d Green [6], colony borders of meroclones were also continuous
t more wrinkled. Finally, paraclones did not have continuous
rders and consisted of large, elongated, fibroblast-like cells
igure 1A). Immunofluorescence microscopy confirmed that the
erage area covered by a holoclone colony was 4 or 16 times less than
e average mero- or paraclone colony, respectively (Figure 1B and
ppl. Figure 1D). The number of cells per colony was marginally butPO
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Neoplasia Vol. 21, No. 2, 2019 Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 Tièche et al. 189gnificantly lower in paraclones than mero- and holoclones (1.5-fold
d 1.33-fold, respectively). Average cell area in paraclones was 2.5-
ld and 9-fold larger than in mero- and holoclones, respectively.
ifferences in nuclear area were less pronounced, resulting in a 3-fold
d 1.5-fold smaller ratio of the nuclear versus the total cellular area in
ra- and meroclones than holoclones, respectively (Figure 1B).
btypes Are Characterized by Distinct mRNA Expression
rofiles
The differences in cell and colony morphology suggest that gene
pression is differentially regulated in the three cellular subtypes. To
oid selection bias, we used a genome-widemRNA expression analysis.
incipal component analysis revealed that the subcultures of the same
pe tightly clustered with each other and there was no overlap with the
her subtypes or the parental population (Figure 2A).
Expression of 2908, 402, and 1848 genes differed significantly
tween parental A549 cultures and holo-, mero-, and paraclonal
ltures, respectively (Figure 2B, adjusted P N .01, Suppl. File
ieche RNA-Seq DATA). We used KEGG pathway enrichment
alysis (GOseq) to determine the dysregulated biological themes in
r dataset (Suppl. File Tieche RNA-Seq DATA/KEGG*). The
thways “ribosome” and “aminoacyl-tRNA biosynthesis,” which are
th related to protein synthesis, were both significantly dysregulated
the comparison of holo- versus paraclone cells and also in holo-
rsus meroclone cells, indicating that these pathways are specifically
sregulated in holoclone cells (Suppl. File Tieche RNA-Seq DATA/
EGG*). The majority of remaining pathways specifically dysregu-
ted in holoclone cells were related to metabolism (i.e., galactose
etabolism, arginine and proline metabolism, and propanoate
etabolism). Paraclone cells were characterized by the dysregulation
pathways involved in cell mobility/migration (i.e., leukocyte
ansendothelial migration and axon guidance). Remarkably, none of
e KEGG pathways was specifically dysregulated in meroclone cells.
deed, the expression of only 30 and 63 genes was specifically up- or
wnregulated, respectively, in meroclone cells compared to the two
her subtypes (Suppl. File Tieche RNA-Seq DATA/mero*).
Our GOseq analysis indicated that none of the KEGG pathways
sociated with stemness (e.g., self-renewal and pluripotency) were
sregulated in our subtypes. Conversely, selected genes that are
sociated with stemness in the context of lung cancer were
fferentially expressed in our subtypes. In detail, expression of
YCL encoding L-MYC, which is amplified and expressed in human
all cell lung cancer (SCLC) [18], was 20 times greater in holo- than
raclone cells (Figure 2C and Suppl. File Tieche RNA-Seq DATA).
owever, cellular Myc (MYC) and N-Myc (MYCN) were not
fferentially expressed. Similarly, expression of the transcription
ctors SOX2 and KLF5 was 67 and 3.1 times higher in holo- than
raclone cells, respectively, whereas expression of OCT4 (POU5F1)
d KLF4 was not dysregulated. Thus, our analysis indicates that the
neral pathways annotated in the KEGG database are only partially
itable for detecting expression differences in different types of lung
ncer cells.
We analyzed expression of selected genes that are specifically
sociated with lung cancer stem cell markers, EMT, and migration/
vasion (Figure 2C). EpCAM and ABCG2 are associated with tumor
itiation capacity in lung cancer (reviewed in [19]) and were indeed
ghly overexpressed in holo- compared to paraclone cells. However,
e putative lung CSC markers ALDH1B, CD44, and CD166
LCAM) [20] were not differentially expressed. Interestingly,HY1, also known as CD90, which was also described as lung TIC
arker [21], was reciprocally expressed compared to other cancer
em cell markers. The epithelial phenotype of holoclone cells was
rther corroborated by the increased expression of the epithelial
arkers E-cadherin (CDH1) and Cadherin 17 (CDH17) and the
sence of the mesenchymal markers THY1 and Vimentin (VIM) and
e mesenchymal transcription factors ZEB2, SNAIL (SNAI1), and
UG (SNAI2). Paraclone cells were characterized by a reciprocal
pression phenotype (Figure 2C).
EMT is associated with migration and invasion (reviewed in [1]).
GF-β and IL-6 induce EMT, and their expression was higher in
ra- than holoclone cells. The receptor tyrosine kinase AXL induces
MT and regulates the function of breast cancer stem cells [22]. AXL
pression was 13 times higher in para- than holoclone cells.
athepsin B (CTSB) and matrix metalloproteinase-2 (MMP2), which
e involved in extracellular matrix remodeling, were expressed 3.9-
d 142-fold less in holo- than paraclone cells, respectively.
terestingly, silencing the expression of the immunomodulator
-L1 in human gastric cancer cells suppresses not only cell
oliferation but also migration and invasion [23]. Indeed, expression
CD274 encoding PD-L1 was 37-fold increased in para- compared
holoclone cells. Besides PD-L1, multiple targetable immune
eckpoint molecules are highly expressed in lung adenocarcinoma
aracterized by an inflammatory tumor microenvironment, which
as highly associated with EMT [24]. Indeed, PDCD1LG2 encoding
-L2 was ranked as the 119th most dysregulated gene in holo-
mpared to paraclone cells, its expression being 235-fold higher in
ra- than holoclone cells (Suppl. File Tieche RNA-Seq DATA).
In summary, holoclone cells are characterized by an increased
pression of epithelial genes and genes associated with lung-specific
emness and cancer stem cell markers. The mRNA expression
ttern of paraclone cells is associated with a mesenchymal
enotype. Interestingly, the immunomodulators PD-L1 and PD-
are both highly overexpressed in para- versus holoclone cells.
eroclone cells display an intermediate expression phenotype.
btypes Have Distinct DNA Methylation Profiles
We next analyzed DNA methylation in the promoter region of
AI2 and CDH1. Pyrosequencing of bisulfide-converted genomic
NA [25] revealed more methylation in the CDH1 promoter region
para- than holoclone cells (Suppl. Figure 2A). In paraclone cells,
ethylation levels inversely correlated with mRNA expression of
DH1, indicating the functional significance of DNA methylation
r transcription regulation of CDH1. In the SNAI2 promoter, no
gnificant subtype-specific methylation differences were detected
uppl. Figure 2A). All subtypes and the parental cell line showed low
vels of methylation in the SNAI2 promoter. These results indicate
at DNA methylation is involved in the transcriptional repression of
e epithelial marker CDH1 in paraclone cells.
btype-Specific Protein Expression of Cell-Surface and Stem-
ell Markers
We extended the characterization of the different cellular subtypes
the protein level. We investigated the localization of differentially
pressed proteins by immunofluorescence microscopy. Indeed,
clear expression of the stemness transcription factor SOX2 and
ll surface expression of the epithelial marker CDH1, i.e., E-
dherin, were higher in holo- than paraclone cells. Protein levels of
e transcription factor ZEB2 and the cytoplasmic protein
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Figure 3. Holo-, mero-, and paraclone cells display phenotypic plasticity over time. (A) Analysis of purified clonal cultures and the parental
cell line A549. (B) Analysis of plasticity by flow cytometry over time [e.g., passage 3, 6, and 10 (P3, P6, and P10, respectively)]. Cultures
were established from single colonies without the purification procedure. Holo-, mero-, and paraclone cells featured a CD90−/SOX2+,
CD90−/SOX2−, and CD90+/SOX2− expression phenotype, respectively. Arrows indicate plasticity trends. P0 shows a phase contrast
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ere higher in para- than holoclone cells (Figure 2D and Suppl.
igure 2B).In agreement with the gene expression analysis (Figure 2C),
ulticolor flow cytometry analysis of purified cultures revealed that
oloclone cells cannot be unambiguously distinguished from
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ith SOX2 or with CD90 expression (Suppl. Figure 3A). However,
loclone cells can be identified by high SOX2 (SOX2+) and low
D90 expression (CD90−). Paraclone cells are characterized by a
ciprocal expression pattern (e.g., SOX2−/CD90+), whereas the
sence of both markers characterizes meroclone cells (e.g., SOX2−/
D90−) (Figure 3A). Within the parental population, our gating
rategy revealed that approximately, 50%, 40%, and 10% of cells
atured a para-, mero-, and holoclonal expression phenotype,
spectively (Figure 3A), which is in agreement with our visual
antification [17].
btypes Display Phenotypic Plasticity Over Time
During the process of purifying cultures, we observed that
orphological homogenous subpopulations frequently give rise to
lls and colonies displaying distinctly different morphological
atures, indicating that the cells can switch from one morphological0123 6 1 0 2 0
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tected in nonpurified holoclonal cultures did not increase over time
igure 3B, see also Suppl. Figure 3C).
After 6 weeks, cultures that started from nonpurified meroclone
lls (SOX2−/CD90−) displayed phenotypic plasticity towards only
e of the other phenotypes [e.g., the meroclone 2.20 showed2 0
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192 Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 Tièche et al. Neoplasia Vol. 21, No. 2, 2019asticity toward a holoclonal phenotype, whereas clone 2.22 displayed
asticity toward a paraclonal phenotype (Figure 3B, see also Suppl.
gure 3C clone 2.21)]. Long-term culture of nonpurified paraclone cells
OX2−/CD90+) initially gave rise to another subpopulation featuring a
X2+/CD90− phenotype characteristic of meroclone cells (P3), which
er time gave rise to a subpopulation with an expression pattern
aracteristic for holoclone cells (i.e., SOX2+/CD90−) (P6/P10).
In summary, holo- and paraclone cells converted to meroclone cells,
hereasmeroclone cells had the highest phenotypic plasticity, giving rise to
bpopulations with a holo- or paraclonal phenotype. Over time, all three
bpopulations gave rise to a small fraction of cells that were characterized
concurrent expression of SOX2+ and CD90+, which is characteristic
r an E/M-hybrid phenotype (Figure 3B and Suppl. Figure 3C).
araclone Cells Are Resistant to Therapies InducingDNADamage
Our experiments revealed that the parental cell line A549 contains
lls that feature a CSC-like or a mesenchymal phenotype, but not
th. Thus, we evaluated the chemotherapy resistance of the A549
llular subtypes. During the exponential growth phase (first 6 days
ter seeding, untreated cultures became confluent), cell growth was
milar for the three untreated subtypes compared to parental A549
lls (Figure 4A). Treating holoclone cell cultures with 10 μM
splatin halted cell growth up to 10 days, and cell numbers showed a
end to decrease between day 10 and day 20. In contrast, the other
ltures resumed growth at day 10 after treatment with 10 μM
splatin. Finally, treatment with 15 μM cisplatin halted growth of
lo- and meroclonal cultures for up to 20 days. Paraclonal cultures
ere even more resistant to high-dose (15 μM) cisplatin treatment
an the parental cell line (day 20). In agreement, cisplatin treatment
lectively reduced the colony formation capacity of holoclone cells
mpared to parental A549 cells. In contrast, colony formation
pacity of paraclone cells was less affected by cisplatin treatment
mpared to parental A549 cells (Suppl. Figure 4B).
Our in silico analysis of publicly available retrospective data from
imary lung adenocarcinoma patients treated with chemotherapy
6] indicated that high gene expression of the epithelial markers
pCAM, E-cadherin, and Cadherin 17 was associated with
gnificantly longer overall survival. In contrast, mRNA overexpres-
on of the mesenchymal markers CD90, Vimentin, and MMP2 was
sociated with significantly worse overall survival (Suppl. Figure 4C).
To test whether the increased resistance of paraclone cells is specific
cisplatin, we treated stable cultures with ionizing radiation (IR). Inntrast to cisplatin treatment, parental cells were most resistant to
eatment with 15 Gy IR (Figure 4B, see also Suppl. Figure 4A). Only
ter treatment with 25 Gy IR, cell numbers between day 10 and day
decreased for the parental cell line, whereas cell numbers did not
crease for cultures of paraclone cells. Cultures of holoclone cells
ere most sensitive after treatment with 15 and 25 Gy IR, whereas
ltures of meroclone cells had an intermediate resistance phenotype.
araclone Cells Are Sensitive to AXL Inhibition
To test whether the increased resistance of paraclone cells is specific
therapies inducing DNA damage, we treated stable cultures with
lotinib. Erlotinib is a small-molecule tyrosine kinase inhibitor and is
ed to treat NSCLC (reviewed in [27]). Expression levels of
idermal growth factor receptor (EGFR), the primary target of
rlotinib, were 2.8-fold higher in para- than holoclone cells, whereas
eroclone cells had intermediate expression levels (Suppl. File Tieche
NA-Seq DATA). However, although cultures from all three types
ere statistically more sensitive to treatment with 100 μM erlotinib
an cultures of parental cells, the differences in sensitivity between all
e tested cultures were marginal (Figure 4C).
Thus, our results indicated that paraclone cells were resistant not
ly to the tested DNA damage–inducing therapies but also to the
hibition of EGFR signaling. Therefore, we aimed to identify a
eatment option that specifically targets these otherwise highly
sistant paraclone cells. AXL is a receptor tyrosine kinase whose
pression and function are tightly linked with the expression of an
MT signature (reviewed in [1]). AXL mRNA expression levels were
-fold higher in para- compared to holo- and meroclone cells,
spectively (Figure 2). siRNA-based silencing of AXL blocked A549
bcutaneous tumor growth and increased chemosensitivity [28].
deed, cell numbers of all tested cultures were reduced during the
itial 72 hours of treatment with the AXL-inhibitor R428 (5 and
5 μM) and continued to decrease during the first 3 days of the
covery phase (up to day 6) (Figure 4D). During the extended recovery
ase (day 10-20), cell growth of all cultures recovered. However, cell
mbers of paraclonal cultures were lowest at all tested time points.
hus, paraclone cells proved most sensitive to AXL inhibition.
terestingly, meroclone cells were more resistant to AXL inhibition
mpared to both holo- and paraclone cells. In summary, paraclone cells
ere most resistant to DNA damage–inducing treatment regimens but
ost sensitive to AXL inhibition. Holoclone cells featured a reciprocal
sistance phenotype.
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Figure 6.Holoclonecells feature highest tumor growth and tumor initiation capacity. (A) Representative imagesof tumors explanted6 weeks
after injection of 100,000 cells. (B) Quantification ofweight from tumors described above. Depicted aremedian and interquartile range of four
independent experiments (each color represents one experiment) performedwith four parental populations and four holoclonal (1.1, 1.2, 1.5,
1.10), three meroclonal (2.2, 2.3, 2.4 P4, 2.4 P8), and four paraclonal (3.2, 3.4, 3.7, 3.9) subcultures. Ordinary one-way ANOVA was used for
significance analysis. (C) Tumor-initiating cell frequency was calculated by extreme limiting dilution analysis. (D) Plasticity in vivo: acquisition
of an epithelial phenotype during tumor growth. Detection of E-cadherin expression by immunohistochemistry.
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An EMT phenotype is associated with increased migration,
vasion, and metastatic capacity (reviewed in [1]). Compared to
rental A549 cells, migration capacity was similar in cultures ofero- and paraclone cells but significantly reduced in holoclone cells
igure 5A). The invasion capacity was similar for cultures of parental,
lo-, and meroclone cells. Paraclonal cultures featured a significantly
creased invasion capacity compared to all other cultures (Figure 5B).
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194 Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 Tièche et al. Neoplasia Vol. 21, No. 2, 2019summary, compared to the parental cells, holoclone cells show a
duced migration capacity, whereas paraclone cells feature an increased
vasion capacity.
pithelial-Like Holoclone Cells Feature the Highest Tumor
itiation/Growth Capacity
Lung cancer stem cell marker expression is associated with tumor
itiation capacity [2]. Therefore, we determined the tumor growth
aracteristics of the different A549 subpopulations. Six weeks after
bcutaneous cell implantation of 100,000 cells, tumors developed
om all subtypes (Figure 6A). Implantation of holoclone cells resulted
tumors with a slightly lower average tumor weight compared to the
rental cell line, although the difference was not statistically significant
igure 6B). However, the average weight of tumors derived from
eroclone cells was significantly lower compared to tumors from
loclone cells and lowest in tumors from paraclone cells.
Since the capacity to initiate tumors might be different from the
pacity to support tumor growth, we determined the tumor
itiation cell (TIC) frequency by extreme limiting dilution assay.
e determined a frequency of 1 TIC per 72.6 parental A549 cells
igure 6C and Suppl. Figure 6). Compared to parental A549 cells,
e TIC frequency of holoclone cells was 7.1-fold increased. In
ntrast, compared to parental cells, the TIC frequency of mero- and
raclone cells was reduced by a factor of 3.4 and 37.9, respectively.
summary, the TIC frequency of holoclone cells was 24.2- and 269-
ld higher compared to mero- and paraclone cells, respectively.
lasticity In Vivo: Acquisition of an Epithelial Phenotype
uring Tumor Growth
We observed phenotypic plasticity during in vitro cultivation of the
llular subtypes; therefore, we investigated whether in vivo tumor
owth also promotes plasticity. Indeed, cultures of the parental cell
e established from xenograft tissue also displayed an increased
action of meroclone cells (N80%, Suppl. Figure 7) compared to the
iginal in vitro culture of parental A549 cells (50%, see [17]).
milarly, compared to the initial purified in vitro cultures (purified to
5%), the fraction of meroclonal colonies after xenotransplantation
creased in both holo- and paraclonal cultures (~40% and ~60%,
spectively, Suppl. Figure 7). Interestingly, meroclonal cultures
mained rather pure during in vivo growth (fraction of holoclone and
raclone cells both below 5%, Suppl. Figure 7).
To exclude that the observed plasticity is an in vitro cultivation
tifact, we also directly stained xenograft tumor tissue by
munohistochemistry (Figure 6D). Membranous E-cadherin ex-
ession was detectable in control cytoblocks of in vitro cultures from
rental, holo-, and meroclone cells but absent in blocks from
raclonal cultures. Interestingly, dramatically increased E-cadherin
pression was detected in all xenograft tumors.A
m
su
re
In
ce
cu
at
fr
aliscussion
e showed that the untreated parental A549 cell line contains
bpopulations characterized by distinct molecular and morpholog-
al features. In their seminal study, Barrandon and Green reported
at primary cultures of human epidermal cells contain three distinct
bpopulations, which feature specific colony-forming potential [6].
terestingly, holo-, mero-, and paraclones were also found in various
man cancer cell lines [7,9,10,29,30]. Morphologically distinct
ones were isolated from the cell line A549 by Ye et al. [16].
owever, they apparently applied a less stringent definition of theiginal categories than that proposed by Barrandon and Green [6].
or example, we categorized colonies featuring noncontinuous colony
rders as paraclones, whereas such colonies, or at least a fraction of
em, were categorized as meroclones by Ye et al. [16]. Ye et al.
ported that holoclones gave rise to spheres with a stem cell–like
enotype, which agrees with our findings that holoclones have the
ost stem-like phenotype.
Andriani et al. recently identified coexisting subpopulations with an
ithelial, mesenchymal, or hybrid-E/M phenotype in A549 [31].
owever, they reported an epithelial phenotype in 82% of A549 cells,
hereas we found even the combined fraction of holo- and meroclone
lls to be smaller. These differences might be due to the study-specific
vitro culture conditions. Thus, it could be interesting to determine
hich factor or factors of the growth media determine the frequency of
e cellular states within a cell culture. Similarly, it would be interesting
determine how the frequency of the cellular states responds to
anges in their growth environment in vivo, e.g., determine the
stribution of the cellular states not only after subcutaneous (Suppl.
igure 7) but also after orthotopic transplantation.
It has been shown in glioma, head and neck squamous cell
rcinoma, and breast and prostate carcinoma cell lines that clones
ith a tight, intermediate, and loose morphology do exist, i.e., holo-,
eso-, and paraclone cells, respectively [8–11]. Thus, the presence of
stinct subpopulations is not restricted to A549 or lung cancer cells
es but might be a distinct feature of a subset of cancer cell lines.
bpopulations can be identified in primary cultures of normal cells
] and might occur in normal cell lines.
Barrandon and Green concluded that the transition of primary
ratinocytes from holoclones to meroclone to paraclones is
idirectional and results in progressively restricted growth potential
]. However, in the context of malignant cells, in vitro and in vivo,
rious TIC markers display phenotypic plasticity (i.e., marker-
gative cells gain expression of a putative TIC marker over time or
ce versa) [12–14,32]. We found that the three cell states can be
entified by their differential SOX2 and CD90 mRNA and protein
pression levels. Expression of the TIC markers CD133, ALDH,
d a side population in A549 cells displays dynamic conversion [14].
e also found a phenotypic plasticity of the three states.
The phenotypic plasticity indicates that the underlying molecular
echanisms guiding the phenotypic changes are reversible. We
sume that the changes are not due to genetic alterations since the
obability is negligible that spontaneous mutations repetitively give
se to identical phenotypical changes, not to say for the acquisition of
identical, reverting mutation. Regulation of the phenotypic
asticity in the context of EMT is complex and multilayered, with
verse growth factors, micro-RNAs, and epigenetic alterations [5].
e found that DNA methylation is involved in the transcriptional
pression of the epithelial marker CDH1 in the paraclone cell clones.
dditional studies will be needed to elucidate the network of
echanisms regulating the frequency and the stability of the
bpopulations.
Relative to holo- and meroclone cells, paraclone cells were more
sistant to chemotherapy and radiation treatment (Figure 4).
terestingly, although the fraction of paraclone cells in the parental
ll line was only 45% and thus much lower than in a pure paraclone
lture, the parental cell line was most resistant to radiation treatment
lower doses. Similarly, the average weight of tumors established
om parental cells was at least as high as those from holoclone cells,
though the tumor initiation frequency of holoclone cells was higher
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Neoplasia Vol. 21, No. 2, 2019 Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 Tièche et al. 195an that of the parental cell line. Interestingly, the tumor initiation
pacity of A549 cells is significantly increased by adding
esenchymal stem cells but not by WI38 human lung fibroblasts
3]. Secretion of IL-6 from mesenchymal stem cells enhanced sphere
rmation and tumor initiation capacity of A549 cells. Indeed, IL-6
ne expression was high in paraclone cells but barely detected in
loclone cells (278-fold difference). Thus, it is tempting to speculate
at holoclone cells serve as tumor-initiating cells, whereas paraclone
lls provide a mesenchymal niche supporting holoclone cells via
racrine signaling. We found that the immunomodulators PD-L1
d PD-L2 are highly overexpressed in para- versus holoclone cells.
ore mesenchymal breast carcinoma cells within a tumor retained
e ability to protect their more epithelial counterparts from immune
tack [34]. Thus, the different clones described here might be an
eal tool to determine if paraclone cells mimic in vitro the
munosuppressive function of distinct tumor subpopulations or
mor-associated stroma cells. Additionally, our results confirmed
at subpopulations do coexist in a dynamic equilibrium.
It has been proposed that CSCs can be defined by their increased
mor initiation capacity and enhanced therapy resistance, which are
th associated with the progression through an EMT (reviewed in
5]. Our results, however, challenge this concept and indicate that the
mor-initiating capacity in lung cancer is associated with an epithelial
enotype and not with a more mesenchymal-like phenotype. In line
ith our results, chemotherapy-resistant lung adenocarcinoma and
ukemia cells are not equivalent to TICs [36]. Further, long-termTICs
aracterized by high levels of EpCAM and CD24 were identified in a
ouse model of SCLC and in human primary SCLC tumors [37].
LC TICs were numerous and highly proliferative but not
trinsically chemoresistant, which agree with our data. Thus, for
ng adenocarcinoma, to the best of our knowledge, it has so far not
en published that chemotherapy resistance and tumor initiation
pacity might be specific features of distinct subpopulations.
Our findings lead to a model of the interplay between stemness,
emotherapy resistance, and molecular and phenotypical plasticity in
ree subpopulations of line A549 (Suppl. Figure 8). We confirmed a
urth subpopulation with concomitant expression of epithelial and
esenchymal markers indicating a hybrid-E/M phenotype, which was
scribed by others [38,39]. In this study, we did not isolate clones with
hybrid-E/Mphenotype. Thus, we conclude that the holo-, mero-, and
raclonal states build a plastic tristable system as reported [38]. Jolly
al. postulated that a tristable system is due to the strong mutual
hibition between two transcription factors coupled with strong self-
tivation of both. In an extension of this model, the hybrid-E/M state
ost probably represents an additional state with weaker bifurcation
ints towards the alternative states. Thus, it will be interesting to
termine the mechanism underlying this plasticity.
Our model supports the hypothesis that drugs inducing a MET
ight significantly increase the efficiency of standard chemotherapy
eviewed in [1]). In the context of lung cancer, we showed that
empferol treatment induced a MET in NSCLC cell lines and
imary cultures as indicated by loss of vimentin expression and
ncomitant induction of E-cadherin expression, which was
sociated with reversal of MTA resistance [40]. Interestingly,
duction of a MET by transduction of reprogramming factors in
man squamous cell carcinoma cells reduced metastatic potential
d size after xenotransplantation [41]. Thus, induction of a partial
ET might decrease chemoresistance but not fully restore tumor
itiation capacity. However, a partial METmight induce a hybrid-E/phenotype, associated with increased tumor initiation capacity and
emotherapy resistance.
onclusions
ur study suggests that that the parental cell line A549 contains
bpopulations characterized by distinct epigenetic states and
enotypical features. The current dogma suggests that cancer stem
lls have a stem-like phenotype and are chemoresistant. Thus, our
alysis indicates that, at least in lung cancer, the situation might be
ore complex. Additionally, our protocol for isolating subpopula-
ns from the A549 line might provide a unique system to dissect the
olecular network underlying stemness, tumor initiation, therapy
sistance, and metastasis in lung cancer.
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